MARA Holdings
MARA
MicroStrategy
MSTR
Tesla
TSLA
Coinbase
COIN
NVIDIA
NVDA
US Stock MarketDetailed Quotes
PHAT Phathom Pharmaceuticals
- 7.740
- +0.410+5.59%
Close Jan 3 16:00 ET
- 7.740
- 0.0000.00%
Post 18:34 ET
529.24MMarket Cap-1.35P/E (TTM)
7.790High7.340Low816.57KVolume7.380Open7.330Pre Close6.24MTurnover1.47%Turnover RatioLossP/E (Static)68.38MShares19.71052wk High-2.83P/B431.32MFloat Cap6.06552wk Low--Dividend TTM55.73MShs Float64.540Historical High--Div YieldTTM6.14%Amplitude5.840Historical Low7.643Avg Price1Lot Size
Phathom Pharmaceuticals News
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Nabulsi Azmi
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Henderson Molly
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director KARBE FRANK
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Parikh Asit
Phathom Pharmaceuticals | 8-K: Current report
Phathom Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.2%)
Phathom Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
Phathom Pharmaceuticals | 8-K: Phathom Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates
Phathom Pharmaceuticals | SCHEDULE 13G/A: Others
Phathom Pharmaceuticals | SCHEDULE 13G: Others
Phathom Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Jennison Associates LLC(10.4%)
Phathom Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.2%)
Phathom Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-James N. Topper(18.0%),Patrick J. Heron(18.0%), etc.
Phathom Pharmaceuticals | 8-K: Current report
Phathom Pharmaceuticals | 424B5: Prospectus
Phathom Pharmaceuticals | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
Phathom Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Phathom Pharmaceuticals | 8-K: Phathom Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
Phathom Pharmaceuticals | 8-K: Current report
Phathom Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Nabulsi Azmi
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.